Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    17785421 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed A Combination Trial of Copaxone Plus Estriol in Relapsing Remitting Multiple Sclerosis (RRMS)
Condition: Relapsing Remitting Multiple Sclerosis
Interventions: Drug: Estriol;   Drug: Placebo

Indicates status has not been verified in more than two years